{
  "retracted": false,
  "timestamp": 1553299200000,
  "updates": [
    {
      "timestamp": 1574896012894,
      "identifier": {
        "doi": "10.1007/s10637-019-00757-9"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10637-012-9910-y"
  },
  "journal": "Investigational New Drugs",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor"
}
